Herudover bør samtidig indgift af Rebetol og stavudin undgås for at begrænse risiko for overlappende mitokondrietoksicitet.
Moreover, co-administration of Rebetol and stavudine should be avoided to limit the risk of overlapping mitochondrial toxicity.